JP2010534225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534225A5 JP2010534225A5 JP2010517434A JP2010517434A JP2010534225A5 JP 2010534225 A5 JP2010534225 A5 JP 2010534225A5 JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010534225 A5 JP2010534225 A5 JP 2010534225A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- day
- skin
- hyaluronic acid
- daltons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705349A FR2919185B1 (fr) | 2007-07-23 | 2007-07-23 | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses |
| PCT/FR2008/000959 WO2009024677A2 (fr) | 2007-07-23 | 2008-07-04 | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de la fonction de protection de la peau, de l'oeil et des muqueuses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010534225A JP2010534225A (ja) | 2010-11-04 |
| JP2010534225A5 true JP2010534225A5 (https=) | 2011-08-18 |
Family
ID=39088885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517434A Ceased JP2010534225A (ja) | 2007-07-23 | 2008-07-04 | 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8895532B2 (https=) |
| EP (1) | EP2167102B1 (https=) |
| JP (1) | JP2010534225A (https=) |
| KR (1) | KR20100059786A (https=) |
| CN (1) | CN101801391B (https=) |
| BR (1) | BRPI0814446A2 (https=) |
| ES (1) | ES2588190T3 (https=) |
| FR (1) | FR2919185B1 (https=) |
| WO (1) | WO2009024677A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010003797A1 (en) * | 2008-07-09 | 2010-01-14 | Novozymes Biopharma Dk A/S | Hyaluronic acid for corneal wound healing |
| FR2963240B1 (fr) * | 2010-07-28 | 2013-03-15 | Horus Pharma | Composition a usage topique sans conservateur comprenant de l'acide hyaluronique |
| US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
| US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
| KR102238406B1 (ko) | 2011-06-03 | 2021-04-08 | 알러간 인더스트리 에스에이에스 | 항산화제를 포함하는 피부 충전제 조성물 |
| ES2667854T3 (es) * | 2011-07-07 | 2018-05-14 | Holy Stone Healthcare Co., Ltd. | Composición para uso en el tratamiento y la prevención de trastornos relacionados con la inflamación |
| TWI466675B (zh) | 2011-09-16 | 2015-01-01 | Univ China Medical | 用於抑制發炎之醫藥組合物 |
| CN102669681A (zh) * | 2012-06-09 | 2012-09-19 | 东莞市照燕生物科技有限公司 | 一种保护胃肠粘膜的营养保健品 |
| ES2627868T3 (es) | 2012-10-25 | 2017-07-31 | Mdt Int'l S.A. | Composiciones mucoadhesivas que comprenden ácido hialurónico y quitosano para aplicación tópica |
| JP2015063510A (ja) * | 2013-06-28 | 2015-04-09 | キユーピー株式会社 | 肌の保湿機能向上に関わる保湿関連遺伝子発現促進剤 |
| EP3328353B1 (en) | 2015-07-27 | 2024-04-10 | Mary Kay, Inc. | Topical skin formulations |
| JP6718728B2 (ja) * | 2016-04-06 | 2020-07-08 | キユーピー株式会社 | アンチポリューション剤およびアンチポリューション用皮膚外用組成物 |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| CN115317504A (zh) * | 2021-05-10 | 2022-11-11 | 傅毓秀 | 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途 |
| WO2022236599A1 (zh) * | 2021-05-10 | 2022-11-17 | 傅毓秀 | 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途 |
| WO2022236585A1 (zh) * | 2021-05-10 | 2022-11-17 | 傅毓秀 | 玻尿酸用于制备治疗肺纤维化药剂的用途 |
| TWI816119B (zh) * | 2021-05-10 | 2023-09-21 | 國立陽明交通大學 | 玻尿酸用於製備治療急性呼吸窘迫症藥劑之用途 |
| WO2023079072A1 (en) | 2021-11-05 | 2023-05-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| EP4683647A1 (en) * | 2023-03-22 | 2026-01-28 | Institut National de la Santé et de la Recherche Médicale | Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4303676A (en) * | 1980-03-21 | 1981-12-01 | Balazs Endre A | Hyaluronate based compositions and cosmetic formulations containing same |
| US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| JPS59219209A (ja) * | 1983-05-28 | 1984-12-10 | Kanebo Ltd | 皮膚化粧料 |
| IT1260148B (it) * | 1992-04-17 | 1996-03-28 | Fidia Spa | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo |
| ITPD980168A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara |
| DE10111165A1 (de) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen |
| DE10161149B4 (de) | 2001-12-12 | 2007-03-08 | Ursapharm Arzneimittel Gmbh & Co. Kg | Verwendung von Heparin-haltigem Ophthalmikum |
| DE10161110A1 (de) | 2001-12-12 | 2003-06-26 | Ursapharm Arzneimittel Gmbh | Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung |
| US7241456B2 (en) * | 2002-10-25 | 2007-07-10 | Australian Importers Ltd. | Formulations for topical delivery of bioactive substances and methods for their use |
| FR2847818B1 (fr) * | 2002-11-28 | 2008-04-04 | Agro Ind Rech S Et Dev Ard | Composition pharmaceutique a base d'acide hyaluronique |
| CN101123942A (zh) * | 2005-01-03 | 2008-02-13 | 诺维信生物聚合物公司 | 具有保湿和抗皱纹性质的透明质酸级分 |
| JP4576583B2 (ja) * | 2005-03-22 | 2010-11-10 | キユーピー株式会社 | ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
-
2007
- 2007-07-23 FR FR0705349A patent/FR2919185B1/fr active Active
-
2008
- 2008-07-04 JP JP2010517434A patent/JP2010534225A/ja not_active Ceased
- 2008-07-04 US US12/670,219 patent/US8895532B2/en active Active
- 2008-07-04 EP EP08827623.3A patent/EP2167102B1/fr active Active
- 2008-07-04 KR KR1020107001664A patent/KR20100059786A/ko not_active Ceased
- 2008-07-04 BR BRPI0814446-0A2A patent/BRPI0814446A2/pt not_active IP Right Cessation
- 2008-07-04 CN CN2008801063138A patent/CN101801391B/zh not_active Expired - Fee Related
- 2008-07-04 WO PCT/FR2008/000959 patent/WO2009024677A2/fr not_active Ceased
- 2008-07-04 ES ES08827623.3T patent/ES2588190T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534225A5 (https=) | ||
| US10758561B2 (en) | Composition based on xyloglucan and proteins for the treatment of intestinal disorders | |
| JP2010515682A5 (https=) | ||
| ME02448B (me) | Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta | |
| WO2012000377A1 (zh) | 包含左卡尼汀和羟苯磺酸盐的药物组合物 | |
| US20230331792A1 (en) | New multi-functional oligopeptides | |
| CN102166219B (zh) | 一种鼻腔给药制剂及其应用 | |
| JP2008533131A5 (https=) | ||
| JP2008501316A5 (https=) | ||
| EP2251016A3 (en) | Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract. | |
| KR101045368B1 (ko) | 베타닌을 유효성분으로 포함하는 위장질환 예방 또는 치료용 조성물 | |
| CN102488697B (zh) | 一种寡聚甘露糖醛酸在制备抗甲型h1n1流感病毒药物中的应用 | |
| US20230113836A1 (en) | New conjugates of peptides and polysaccharide | |
| US20150094266A1 (en) | Xyloglucan and protein compositions for the treatment of intestinal disorders | |
| CN103446165A (zh) | 低聚古罗糖醛酸在制备预防和治疗酒精性肝损伤的药物、保健品或饮食补充剂中的应用 | |
| Stancic-Rokotov et al. | Lung lesions and anti-ulcer agents beneficial effect: Anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats | |
| WO2009004649A3 (en) | Enteric coated pharmaceutical compositions | |
| JP2016512250A5 (https=) | ||
| CA2645574A1 (en) | A medicine used for curing hyperphosphatemia and its preparation method | |
| CN105085455A (zh) | 唾液酸类似物或其药学上可接受的盐及其应用 | |
| NO20083213L (no) | Farmasoytisk sammensetning inneholdende montelukast | |
| CN106361718B (zh) | 单唾液酸四己糖神经节苷脂钠的结肠靶向生物粘附片 | |
| ITUB20155754A1 (it) | Composizione per il trattamento di malattie imfiammatorie intestinali. | |
| US20140364390A1 (en) | Xyloglucan-based compositions for the treatment of gastrointestinal disorders | |
| CN102276590B (zh) | 一种金线莲提取物自旋标记类似物及制备与用途 |